The New Biology of Lung Cancer: Changing Paradigms in Personalized Medicine

Physicians Education Resource
Archivio
-
05.06.2010  Chicago
Not an official event of the ASCO Annual Meeting. Not sponsored or endorsed by ASCO or the ASCO Cancer Foundation.
 
Contenuti (corsi)
CME-certified satellite symposium, will inform participants of the emerging diversity of lung cancer and the implications for individualized therapy. The newfound importance of biomarkers in treatment decision making will be emphasized, followed by other current topics of interest, such as maintenance therapy. Selected use of targeted agents, including EGFR and angiogenesis inhibitors, will be discussed, as will novel targets including EML4-ALK. Didactic lectures from lung cancer experts will...
Obiettivi didattici, obiettivi del training
Please see our websie for all the details www.cancerlearning.com
Pubblico target
This educational program is directed toward medical, surgical, and radiation oncologists interested in the treatment of patients with lung cancer. Fellows, nurse practitioners, nurses, physician assistants, pharmacists, researchers, and other health
Annotazioni
http://www.cancerlearning.com/index.cfm/fuseaction/conference.showOverview/id/5/conference_id/541
 

Informazioni ed Iscrizioni:

Mr. Duane Fowler
 
Categorie
Oncologia
Lingua
Inglese
Costi
complimentary
Contatto organizzatori
3500 Maple Ave. Ste. 700
75219 Dallas
USA
 
"Noi, Going International, siamo un’azienda che si è scelta come obiettivo di rendere acessibile la formazione a una grandissima quantità di persone, oltrepassanddo i confini geografici e sociali."

European Health Forum GasteinnewTreeAGEM - Arbeitsgemeinschaft Ethnologie und MedizinAMREF - African Medical and Research FoundationÄrzte der WeltEuropean Public Health Association (EUPHA)OÖ Gebietskrankenkasse, Referat für Wissenschaftskooperation Centro per la Formazione Permanente e l'Aggiornamento del Personale del Servizio Sanitario